Suppr超能文献

环状RNA CDR1as作为miR-135b-5p的海绵,抑制卵巢癌进展。

Circular RNA CDR1as acts as a sponge of miR-135b-5p to suppress ovarian cancer progression.

作者信息

Chen He, Mao Min, Jiang Jing, Zhu Daling, Li Peiling

机构信息

Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, People's Republic of China.

Department of Biopharmaceutical Sciences, Harbin Medical University, Daqing 163319, People's Republic of China.

出版信息

Onco Targets Ther. 2019 May 17;12:3869-3879. doi: 10.2147/OTT.S207938. eCollection 2019.

Abstract

Ovarian cancer is the most fatal primary malignancy among gynecological cancers. Circular RNAs (circRNAs) play an important role in the development of various cancers, but the functions of circRNAs in ovarian cancer development have not been studied. We aim to explore the function and mechanism of CDR1as in the progression of ovarian cancer and to provide a new target for the diagnosis and treatment of ovarian cancer. Ovarian cancer cell proliferation was assessed according to proliferating cell nuclear antigen (PCNA) and Ki67 protein expression levels and MTT and CCK8 assays. The migration ability of cells was detected by scratch-wound assays, and the invasion ability of the cells was determined by Transwell assays. qRT-PCR and Western blotting were used to verify miRNA and protein expression. CDR1as expression in ovarian tissues was significantly lower in ovarian cancer patients than in patients without ovarian cancer. CDR1as overexpression inhibited the proliferation, invasion and migration of ovarian cancer cells. Silencing CDR1as increased the expression of miR-135b-5p and decreased the expression of hypoxia-inducible factor 1-alpha inhibitor (HIF1AN), thus increasing the proliferation capacity of ovarian cancer cells. CDR1as, acting as a sponge of miR-135b-5p, promotes the expression of HIF1AN and therefore plays a role in tumor inhibition.

摘要

卵巢癌是妇科癌症中最致命的原发性恶性肿瘤。环状RNA(circRNA)在各种癌症的发展中发挥着重要作用,但circRNA在卵巢癌发展中的功能尚未得到研究。我们旨在探讨CDR1as在卵巢癌进展中的功能和机制,并为卵巢癌的诊断和治疗提供新的靶点。根据增殖细胞核抗原(PCNA)和Ki67蛋白表达水平以及MTT和CCK8检测评估卵巢癌细胞增殖。通过划痕试验检测细胞的迁移能力,通过Transwell试验测定细胞的侵袭能力。使用qRT-PCR和蛋白质印迹法验证miRNA和蛋白质表达。卵巢癌患者卵巢组织中CDR1as的表达明显低于无卵巢癌的患者。CDR1as过表达抑制卵巢癌细胞的增殖、侵袭和迁移。沉默CDR1as可增加miR-135b-5p的表达并降低缺氧诱导因子1α抑制剂(HIF1AN)的表达,从而增加卵巢癌细胞的增殖能力。CDR1as作为miR-135b-5p的海绵,促进HIF1AN的表达,因此发挥肿瘤抑制作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验